RECRUITING

Wearable Activity Tracking to Curb Hospitalizations

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study is being done to collect patient generated health data to predict the risk of patients needing emergency department visits or hospitalization before, during. and after receiving radiation therapy.

Official Title

Wearable Activity Tracking to Curb Hospitalizations (WATCH)

Quick Facts

Study Start:2025-04-07
Study Completion:2027-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06587100

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Age \>= 18.
  2. * Eastern Cooperative Oncology Group (ECOG) performance status =\< 2.
  3. * Able to understand study procedures and to comply with them for the entire length of the study.
  4. * Ability of individual or legal guardian/representative to understand a written informed consent document, and the willingness to sign it.
  5. * Diagnosis of invasive malignancy.
  6. * Able to ambulate independently (without the assistance of a cane or walker).
  7. * Planned treatment with fractionated external beam radiotherapy over at least 5 days (no fractional requirement).
  8. * Not a previous participant on this protocol for subsequent courses.
  1. * Participants bound to a wheelchair.
  2. * Participants unable to ambulate independently (needing assistance of cane or walker).

Contacts and Locations

Study Contact

Jamese Johnson
CONTACT
(415) 530-9805
Jamese.Johnson@ucsf.edu

Principal Investigator

Julian Hong, MD, MS
PRINCIPAL_INVESTIGATOR
University of California, San Francisco

Study Locations (Sites)

University of California, San Francisco
San Francisco, California, 94143
United States

Collaborators and Investigators

Sponsor: University of California, San Francisco

  • Julian Hong, MD, MS, PRINCIPAL_INVESTIGATOR, University of California, San Francisco

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-04-07
Study Completion Date2027-12-31

Study Record Updates

Study Start Date2025-04-07
Study Completion Date2027-12-31

Terms related to this study

Keywords Provided by Researchers

  • Activity tracking
  • Hospitalization prevention
  • Artificial Intelligence (AI) modelling

Additional Relevant MeSH Terms

  • Hematopoietic Neoplasm
  • Malignant Solid Neoplasm
  • Lymphatic System Neoplasm